Artwork

Content provided by [email protected] (Gustavo Barra) and Gustavo Barra. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by [email protected] (Gustavo Barra) and Gustavo Barra or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

️ 95: Mitochondria on the Move: Biotechnological Strategies for Transfer and Transplantation

19:10
 
Share
 

Manage episode 499155867 series 3682575
Content provided by [email protected] (Gustavo Barra) and Gustavo Barra. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by [email protected] (Gustavo Barra) and Gustavo Barra or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

️ Episode 95: Mitochondria on the Move: Biotechnological Strategies for Transfer and Transplantation

In this episode of PaperCast Base by Base, we explore recent advances in biotechnological methods for mitochondria transfer and transplantation aimed at restoring cellular function in diseases driven by mitochondrial dysfunction.

Study Highlights:

The authors review current approaches for isolating and delivering mitochondria, including liposomal encapsulation, extracellular vesicle carriers, and surface modifications that improve uptake and stability.

They analyze the role of cell-penetrating peptides, nanomotorized delivery systems, and hydrogels in enhancing targeting efficiency and biocompatibility across cardiovascular and neurodegenerative disease models.

Critical challenges such as immune recognition, scalability, and regulatory barriers are discussed alongside strategies to engineer delivery vehicles that protect mitochondria and facilitate their integration into host mitochondrial networks.

Emerging platforms like synaptosome-based carriers and engineered extracellular vesicles are evaluated for their potential to overcome physiological barriers such as the blood-brain barrier.

Conclusion:

Mitochondria transfer and transplantation represent promising nanotherapeutic strategies for mitochondrial disorders, with future research focusing on developing scalable, safe, and targeted delivery platforms.

Reference:

Kubat GB, Picone P, Tuncay E, Aryan L, Girgenti A, Palumbo L, Turkel I, Akat F, Singh KK, Nuzzo D. Biotechnological approaches and therapeutic potential of mitochondria transfer and transplantation. Nature Communications. 2025;16:5709. doi:10.1038/s41467-025-61239-6

License:

This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/

  continue reading

116 episodes

Artwork
iconShare
 
Manage episode 499155867 series 3682575
Content provided by [email protected] (Gustavo Barra) and Gustavo Barra. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by [email protected] (Gustavo Barra) and Gustavo Barra or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

️ Episode 95: Mitochondria on the Move: Biotechnological Strategies for Transfer and Transplantation

In this episode of PaperCast Base by Base, we explore recent advances in biotechnological methods for mitochondria transfer and transplantation aimed at restoring cellular function in diseases driven by mitochondrial dysfunction.

Study Highlights:

The authors review current approaches for isolating and delivering mitochondria, including liposomal encapsulation, extracellular vesicle carriers, and surface modifications that improve uptake and stability.

They analyze the role of cell-penetrating peptides, nanomotorized delivery systems, and hydrogels in enhancing targeting efficiency and biocompatibility across cardiovascular and neurodegenerative disease models.

Critical challenges such as immune recognition, scalability, and regulatory barriers are discussed alongside strategies to engineer delivery vehicles that protect mitochondria and facilitate their integration into host mitochondrial networks.

Emerging platforms like synaptosome-based carriers and engineered extracellular vesicles are evaluated for their potential to overcome physiological barriers such as the blood-brain barrier.

Conclusion:

Mitochondria transfer and transplantation represent promising nanotherapeutic strategies for mitochondrial disorders, with future research focusing on developing scalable, safe, and targeted delivery platforms.

Reference:

Kubat GB, Picone P, Tuncay E, Aryan L, Girgenti A, Palumbo L, Turkel I, Akat F, Singh KK, Nuzzo D. Biotechnological approaches and therapeutic potential of mitochondria transfer and transplantation. Nature Communications. 2025;16:5709. doi:10.1038/s41467-025-61239-6

License:

This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/

  continue reading

116 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play